NCT03679897View on ClinicalTrials.gov

Comparison of 0.375% Ropivacaine and 0.25% Levobupivacaine for Infraclavicular Brachial Plexus Block

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

December 7, 2018

Study Completion Date

December 8, 2018

Conditions
Regional Anesthesia
Interventions
DRUG

Ropivacaine solution

ultrasound-guided infraclavicular brachial plexus block with 0.375% ropivacaine solution

DRUG

Levobupivacaine solution

ultrasound-guided infraclavicular brachial plexus block with 0.25% levobupivacaine solution

Trial Locations (1)

05505

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT03679897 - Comparison of 0.375% Ropivacaine and 0.25% Levobupivacaine for Infraclavicular Brachial Plexus Block | Biotech Hunter | Biotech Hunter